Literature DB >> 1143521

Proceedings: N-oxidation of sparteine in man and its interindividual differences.

M Eichelbaum, N Spannbrucker, H J Dengler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1143521

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  11 in total

1.  Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers.

Authors:  T Graf; F Broly; F Hoffmann; M Probst; U A Meyer; H Howald
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.

Authors:  John Caldwell
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Es kann die Spur von unseren Erdetagen--on pharmacologists and pharmacology.

Authors:  Klaus Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11       Impact factor: 3.000

4.  3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.

Authors:  Yueying Zhen; Ondrej Slanar; Kristopher W Krausz; Chi Chen; Josef Slavík; Kerry L McPhail; T Mark Zabriskie; Frantisek Perlík; Frank J Gonzalez; Jeffrey R Idle
Journal:  Drug Metab Dispos       Date:  2006-06-16       Impact factor: 3.922

5.  Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations.

Authors:  G Alván; P Bechtel; L Iselius; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Pharmacogenomics: the genetics of variable drug responses.

Authors:  Dan M Roden; Russell A Wilke; Heyo K Kroemer; C Michael Stein
Journal:  Circulation       Date:  2011-04-19       Impact factor: 29.690

7.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02

8.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

Review 9.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Personalized medicine - where do we stand? Pouring some water into wine: a realistic perspective.

Authors:  Ursula Gundert-Remy; Aleksandar Dimovski; Srećko Gajović
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.